Kato M, Kuratani T
Department of Cardiovascular Surgery, Morinomiya Hospital, Morinomiya Jotoku Osaka, Japan.
J Cardiovasc Surg (Torino). 2008 Aug;49(4):503-10.
Japan has a long and successful history of performing thoracic endovascular aneurysm repair (TEVAR). While commercial endovascular grafts were being used worldwide, Japan developed and distributed custom and semi-order made triple-branched one-piece grafts and fenestrated devices for the treatment of arch aneurysms. Historically, Japan also innovated and proposed hybrid procedures such as debranching with stent grafting to treat arch aneurysms and thoracoabdominal aneurysms. Since its introduction, Japan has been at the forefront of performing TEVAR for complicated acute aortic dissection and uncomplicated chronic aortic dissection for patients with predicted aortic enlargement. In this review, the authors discuss the many issues surrounding successful TEVAR, focusing on devices, operative methods, and prevention of complications.
日本在进行胸主动脉腔内修复术(TEVAR)方面有着悠久且成功的历史。当全球都在使用商业血管内移植物时,日本研发并推广了定制和半定制的一体式三分支移植物以及开窗装置,用于治疗主动脉弓部动脉瘤。从历史角度看,日本还创新并提出了诸如支架植入去分支等杂交手术,以治疗主动脉弓部动脉瘤和胸腹主动脉瘤。自引入该技术以来,日本在为预测主动脉会扩大的复杂急性主动脉夹层和非复杂慢性主动脉夹层患者进行TEVAR方面一直处于前沿位置。在这篇综述中,作者讨论了成功实施TEVAR所涉及的诸多问题,重点关注器械、手术方法以及并发症的预防。